Literature DB >> 3190180

Microanalytical high-performance liquid chromatography assay for cefpirome (HR 810) in serum.

C P Turley1, G L Kearns, R F Jacobs.   

Abstract

We report a microanalytical high-performance liquid chromatography method for quantitation of cefpirome (HR 810) from serum. The drug was extracted from 0.05 ml of serum with 0.2 ml of isopropanol containing beta-hydroxypropyltheophylline, the internal standard. Separations were performed on a C18 column at ambient temperature with detection at 240 nm. The mobile phase consisted of acetate buffer (0.05 M sodium acetate) containing tetrabutylammonium hydroxide and methanol (pH 5.1; 70:30, vol/vol). The method was linear to 500 micrograms of cefpirome per ml and had a sensitivity of 0.6 micrograms/ml. Analytical recovery was greater than 86%, and the between-day coefficient of variation was less than 4.2%. The stability for 1 week at 4 to 8 degrees C and for 30 days at -20 degrees C was documented. Interference with commonly used antibiotics, analgesics, methylxanthines, and anticonvulsants was not found. The small sample volume and ease of preparation make this method suitable for use in pediatric pharmacokinetic investigations of cefpirome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190180      PMCID: PMC175902          DOI: 10.1128/AAC.32.10.1481

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Pharmacokinetics of cefpirome (HR 810), a new cephalosporin derivative administered intramuscularly and intravenously to healthy volunteers.

Authors:  L Maass; V Malerczyk; M Verho
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

2.  Precision of "high-performance" liquid-chromatographic assays with sample pretreatment. Error analysis for the Technicon "FAST-LC" system.

Authors:  S van der Wal; L R Snyder
Journal:  Clin Chem       Date:  1981-07       Impact factor: 8.327

3.  In vitro activity of HR 810, a new cephalosporin.

Authors:  M A Bertram; D A Bruckner; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

4.  Treatment of refractory supraventricular arrhythmias with flecainide acetate.

Authors:  J A Till; E Rowland; E A Shinebourne; D E Ward
Journal:  Arch Dis Child       Date:  1987-03       Impact factor: 3.791

5.  Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivate.

Authors:  L Maass; V Malerczyk; M Verho; P Hajdú; K Seeger; N Klesel
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

6.  Single and multiple dose pharmacokinetics of intravenous cefpirome (HR 810), a novel cephalosporin derivative.

Authors:  V Malerczyk; L Maass; M Verho; P Hajdú; N Klesel; R Rangoonwala
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

7.  In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.

Authors:  R N Jones; C Thornsberry; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

8.  Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.

Authors:  J M Trang; R F Jacobs; G L Kearns; A L Brown; T G Wells; F L Underwood; R B Kluza
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

9.  The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides.

Authors:  G Seibert; M Limbert; I Winkler; T Dick
Journal:  Infection       Date:  1983 Sep-Oct       Impact factor: 3.553

10.  Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.

Authors:  R N Jones; C Thornsberry; A L Barry; L Ayers; S Brown; J Daniel; P C Fuchs; T L Gavan; E H Gerlach; J M Matsen
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

  10 in total
  2 in total

Review 1.  Cefpirome clinical pharmacokinetics.

Authors:  L C Strenkoski; D E Nix
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

2.  New Stability Indicating RP-HPLC Method for the Estimation of Cefpirome Sulphate in Bulk and Pharmaceutical Dosage Forms.

Authors:  Kareti Srinivasa Rao; Keshar Nargesh Kumar; Datta Joydeep
Journal:  Sci Pharm       Date:  2011-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.